⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6301679 | 0.66 | — | — | |
| SCHEMBL7798983 | 0.60 | — | — | |
| SCHEMBL5177583 | 0.60 | — | — | |
| SCHEMBL9739087 | 0.59 | — | — | |
| SCHEMBL2380005 | 0.59 | CRBN (0.30) | — | |
| SCHEMBL906328 | 0.58 | — | — | |
| SCHEMBL6301634 | 0.58 | KMT2A (0.30) | — | |
| SCHEMBL11101407 | 0.58 | — | — | |
| SCHEMBL15788805 | 0.57 | — | — | |
| SCHEMBL1936488 | 0.57 | MAPT (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1089980-A1 | COMPOUNDS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS | Elan Pharmaceuticals, Inc. (US) | 2001-04-11 | — | — | EP | disclosed |
| WO-1999067221-A1 | COMPOUNDS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS | ELAN PHARMACEUTICALS, INC. (US) | 1999-12-29 | — | — | WO | disclosed |